Status:

COMPLETED

Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement

Lead Sponsor:

Tomsk National Research Medical Center of the Russian Academy of Sciences

Collaborating Sponsors:

Siberian State Medical University

Conditions:

Hypoxemia

Pneumonia, Viral

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

Preliminary data support the effect of Nitric Oxide (NO) on improving the oxygenation in mechanically ventilated patients and spontaneously breathing patients with COVID-19. In vitro studies showed an...

Detailed Description

Coronavirus disease 2019 (COVID-19) consists mainly of a respiratory infection that spans from a mild involvement of the upper respiratory tract to severe pneumonia leading to respiratory distress, sh...

Eligibility Criteria

Inclusion

  • COVID-19 confirmed by a positive RT-PCR test
  • Hospital admission within 11 days from the onset of symptoms
  • Spontaneous breathing with oxygen requirement ≥1 L/min
  • Expected discharge \> 96 hours at randomization

Exclusion

  • Pregnancy
  • Presence of a tracheostomy
  • Assistance by any non-invasive CPAP or NIV at the screening
  • Treatment with high flow nasal cannula at the screening
  • Clinical contraindication to the use of NO
  • Patients enrolled in another interventional trial
  • Hospitalized and confirmed diagnosis of COVID-19 for more than 7 days
  • Previous intubation for COVID-19
  • Subject not committed to full support (DNR, DNI or CMO)
  • Subject requiring oxygen at home for lung comorbidities
  • The primary cause of hospitalization not due to COVID-19
  • Subject receiving vasopressor at the time of screening
  • History of malignancy or other irreversible disease/conditions with 6-month mortality \>50%
  • Oxygen saturation of 100% at screening, despite oxygen requirement
  • Patients on dialysis at the time of enrollment

Key Trial Info

Start Date :

July 24 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 17 2021

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04476992

Start Date

July 24 2020

End Date

September 17 2021

Last Update

January 26 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences

Tomsk, Russia, 634012

Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement | DecenTrialz